March 07, 2016
An Indian generic drug manufacturer infringed Takeda's and AstraZeneca's patent for the chronic obstructive pulmonary disease drug Daliresp with its recent abbreviated new drug application, according to a lawsuit filed Friday in New Jersey federal court, the latest of about a dozen filed over the drug.